US20060183746A1
(en)
*
|
2003-06-04 |
2006-08-17 |
Currie Kevin S |
Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
|
JP2008533032A
(ja)
|
2005-03-10 |
2008-08-21 |
シージーアイ ファーマシューティカルズ,インコーポレイティド |
或る種の置換アミド、その製造方法及び使用方法
|
US7893058B2
(en)
|
2006-05-15 |
2011-02-22 |
Janssen Pharmaceutica Nv |
Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
|
DK2029602T3
(da)
|
2006-05-31 |
2010-08-09 |
Galapagos Nv |
Triazolopyrazinforbindelser, der kan anvendes til behandling af degenerative og inflammatoriske sygdomme
|
PE20080839A1
(es)
*
|
2006-09-11 |
2008-08-23 |
Cgi Pharmaceuticals Inc |
Determinadas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismas
|
JP2010502751A
(ja)
*
|
2006-09-11 |
2010-01-28 |
シージーアイ ファーマシューティカルズ,インコーポレイティド |
キナーゼ阻害物質、およびキナーゼ阻害物質の使用および同定方法
|
EP2201840B1
(en)
|
2006-09-22 |
2011-11-02 |
Pharmacyclics, Inc. |
Inhibitors of Bruton's Tyrosine Kinase
|
EP2089391B1
(en)
*
|
2006-11-03 |
2013-01-16 |
Pharmacyclics, Inc. |
Bruton's tyrosine kinase activity probe and method of using
|
CN101730699A
(zh)
|
2007-03-21 |
2010-06-09 |
百时美施贵宝公司 |
可用于治疗增殖性、变应性、自身免疫性和炎症性疾病的稠合杂环化合物
|
US20120101114A1
(en)
|
2007-03-28 |
2012-04-26 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase
|
EP2548558A1
(en)
*
|
2007-03-28 |
2013-01-23 |
Pharmacyclics, Inc. |
Nitrogen-containing condensed heterocyclic as inhibitors of bruton's tyrosine kinase
|
US8148369B2
(en)
|
2007-05-10 |
2012-04-03 |
Janssen Pharmaceutica Nv |
Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
|
CN101772500A
(zh)
*
|
2007-06-14 |
2010-07-07 |
先灵公司 |
作为蛋白质激酶抑制剂的咪唑并吡嗪
|
WO2009012283A1
(en)
*
|
2007-07-17 |
2009-01-22 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
ES2444144T3
(es)
|
2007-10-23 |
2014-02-24 |
F. Hoffmann-La Roche Ag |
Nuevos inhibidores de quinasa
|
ES2462642T3
(es)
*
|
2007-12-14 |
2014-05-26 |
F. Hoffmann-La Roche Ag |
Nuevos derivados de imidazo[1,2-a]piridina e imidazo[1,2-b]piridazina
|
US8426441B2
(en)
|
2007-12-14 |
2013-04-23 |
Roche Palo Alto Llc |
Inhibitors of bruton's tyrosine kinase
|
CN102159214A
(zh)
|
2008-07-16 |
2011-08-17 |
药品循环公司 |
用于实体肿瘤的治疗的布鲁顿酪氨酸激酶的抑制剂
|
EP2307418B1
(en)
*
|
2008-07-18 |
2014-03-12 |
F.Hoffmann-La Roche Ag |
Novel phenylimidazopyrazines
|
WO2010011837A1
(en)
|
2008-07-24 |
2010-01-28 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
EP3123864A1
(en)
|
2008-12-08 |
2017-02-01 |
Gilead Connecticut, Inc. |
Imidazopyrazine syk inhibitors
|
AU2009325133B2
(en)
|
2008-12-08 |
2016-02-04 |
Gilead Connecticut, Inc. |
Imidazopyrazine Syk inhibitors
|
WO2010068788A1
(en)
*
|
2008-12-10 |
2010-06-17 |
Cgi Pharmaceuticals, Inc. |
Heterocyclic amides as btk inhibitors
|
CA2747670A1
(en)
|
2008-12-19 |
2010-07-15 |
Bristol-Myers Squibb Company |
Carbazole carboxamide compounds useful as kinase inhibitors
|
JP5656976B2
(ja)
*
|
2009-04-29 |
2015-01-21 |
ローカス ファーマシューティカルズ インコーポレイテッド |
ピロロトリアジン化合物
|
CN102458402B
(zh)
|
2009-06-12 |
2013-10-02 |
百时美施贵宝公司 |
用作激酶调节剂的烟酰胺化合物
|
WO2011051342A1
(en)
|
2009-10-30 |
2011-05-05 |
Janssen Pharmaceutica Nv |
IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
AU2011226689B2
(en)
*
|
2010-03-11 |
2016-09-01 |
Kronos Bio, Inc. |
Imidazopyridines Syk inhibitors
|
MY191929A
(en)
|
2010-06-03 |
2022-07-18 |
Pharmacyclics Llc |
The use of inhibitors of bruton's tyrosine kinase (btk)
|
US8685969B2
(en)
|
2010-06-16 |
2014-04-01 |
Bristol-Myers Squibb Company |
Carboline carboxamide compounds useful as kinase inhibitors
|
BR112013033375B1
(pt)
|
2011-06-27 |
2022-05-10 |
Janssen Pharmaceutica N.V |
Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxa-lina, seu uso, composição farmacêutica que os compreende, processo de preparação dos mesmos, solução estéril e composto intermediário
|
WO2013010136A2
(en)
|
2011-07-13 |
2013-01-17 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase
|
US8586387B2
(en)
*
|
2011-08-30 |
2013-11-19 |
Supernova Diagnostics, Inc. |
Methods of triggering activation of encapsulated signal-generating substances and apparatus utilising activated signal-generating substances
|
WO2013067277A1
(en)
|
2011-11-03 |
2013-05-10 |
Genentech, Inc. |
Alkylated piperazine compounds as inhibitors of btk activity
|
KR101696525B1
(ko)
|
2011-11-03 |
2017-01-13 |
에프. 호프만-라 로슈 아게 |
Btk 활성 억제제로서의 8-플루오로프탈라진-1(2h)-온 화합물
|
UA111756C2
(uk)
|
2011-11-03 |
2016-06-10 |
Ф. Хоффманн-Ля Рош Аг |
Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
|
ES2552514T3
(es)
|
2011-11-03 |
2015-11-30 |
Hoffmann-La Roche Ag |
Compuestos bicíclicos de piperazina
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
TWI662964B
(zh)
|
2012-06-04 |
2019-06-21 |
美商製藥有限責任公司 |
布魯頓氏酪胺酸激酶抑制劑之結晶形式
|
AU2013283426B2
(en)
|
2012-06-26 |
2018-02-22 |
Janssen Pharmaceutica Nv |
Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological or metabolic disorders
|
CN104411314B
(zh)
|
2012-07-09 |
2017-10-20 |
詹森药业有限公司 |
磷酸二酯酶10的抑制剂
|
EP2877598A1
(en)
|
2012-07-24 |
2015-06-03 |
Pharmacyclics, Inc. |
Mutations associated with resistance to inhibitors of bruton's tyrosine kinase (btk)
|
SG11201503842PA
(en)
|
2012-11-15 |
2015-06-29 |
Pharmacyclics Inc |
Pyrrolopyrimidine compounds as kinase inhibitors
|
WO2014125410A1
(en)
*
|
2013-02-12 |
2014-08-21 |
Aurigene Discovery Technologies Limited |
N-substituted heterocyclic derivatives as kinase inhibitors
|
CN104119269A
(zh)
*
|
2013-04-25 |
2014-10-29 |
苏州科捷生物医药有限公司 |
一种6-异丙基烟酸的合成方法
|
EP2989106B1
(en)
|
2013-04-25 |
2016-12-14 |
Beigene, Ltd. |
Fused heterocyclic compounds as protein kinase inhibitors
|
MX2015016771A
(es)
|
2013-06-25 |
2016-03-31 |
Squibb Bristol Myers Co |
Compuestos de carbazol carboxamida utiles como inhibidores de cinasa.
|
TWI648272B
(zh)
|
2013-06-25 |
2019-01-21 |
美商必治妥美雅史谷比公司 |
經取代之四氫咔唑及咔唑甲醯胺化合物
|
CN105358545A
(zh)
|
2013-07-03 |
2016-02-24 |
豪夫迈·罗氏有限公司 |
杂芳基吡啶酮和氮杂-吡啶酮酰胺化合物
|
KR101810798B1
(ko)
|
2013-07-30 |
2017-12-19 |
질레드 코네티컷 인코포레이티드 |
Syk 억제제의 다형체
|
UA115815C2
(uk)
|
2013-07-30 |
2017-12-26 |
Гіліад Коннектікут, Інк. |
Склад на основі інгібіторів syk
|
WO2015017812A1
(en)
|
2013-08-02 |
2015-02-05 |
Pharmacyclics, Inc. |
Methods for the treatment of solid tumors
|
ES2709509T3
(es)
|
2013-08-12 |
2019-04-16 |
Pharmacyclics Llc |
Procedimientos para el tratamiento de cáncer amplificado por HER2
|
JP6623353B2
(ja)
|
2013-09-13 |
2019-12-25 |
ベイジーン スウィッツァーランド ゲーエムベーハー |
抗pd−1抗体並びにその治療及び診断のための使用
|
MA38961A1
(fr)
|
2013-09-30 |
2018-05-31 |
Pharmacyclics Llc |
Composés 3-phenyl-1h-pyrazolo[3,4-d]pyrimidin-4-ylamine substitués inhibiteurs de la tyrosine kinase de bruton utilisés pour traiter par exemple les maladies auto-immunes, respiratoires et inflammatoires, cancer, mastocytose et osteoporose
|
MX2016007311A
(es)
|
2013-12-04 |
2016-09-07 |
Gilead Sciences Inc |
Metodos para tratar canceres.
|
WO2015082583A1
(en)
|
2013-12-05 |
2015-06-11 |
F. Hoffmann-La Roche Ag |
Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality
|
US9290505B2
(en)
|
2013-12-23 |
2016-03-22 |
Gilead Sciences, Inc. |
Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
|
TWI662037B
(zh)
|
2013-12-23 |
2019-06-11 |
美商基利科學股份有限公司 |
脾酪胺酸激酶抑制劑
|
US9885086B2
(en)
|
2014-03-20 |
2018-02-06 |
Pharmacyclics Llc |
Phospholipase C gamma 2 and resistance associated mutations
|
KR102130600B1
(ko)
|
2014-07-03 |
2020-07-08 |
베이진 엘티디 |
Pd-l1 항체와 이를 이용한 치료 및 진단
|
NZ726365A
(en)
|
2014-07-14 |
2018-06-29 |
Gilead Sciences Inc |
Combinations for treating cancers
|
CA2959602A1
(en)
|
2014-08-01 |
2016-02-04 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
MX2017001671A
(es)
|
2014-08-07 |
2017-07-04 |
Pharmacyclics Llc |
Formulaciones novedosas de un inhibidor de la tirosina cinasa de bruton.
|
AR102427A1
(es)
|
2014-10-24 |
2017-03-01 |
Bristol Myers Squibb Co |
Derivados de carbazol inhibidores de quinasas
|
BR112017007563A2
(pt)
|
2014-10-24 |
2017-12-19 |
Bristol Myers Squibb Co |
compostos atropisômeros tricíclicos
|
TWI744218B
(zh)
|
2014-10-24 |
2021-11-01 |
美商必治妥美雅史谷比公司 |
吲哚甲醯胺化合物
|
TWI810588B
(zh)
|
2015-03-03 |
2023-08-01 |
美商製藥公司 |
布魯東氏(bruton’s)酪胺酸激酶抑制劑之醫藥調配物
|
MX2017014436A
(es)
*
|
2015-05-12 |
2018-08-01 |
Kalyra Pharmaceuticals Inc |
Compuestos biciclicos.
|
TW201718581A
(zh)
|
2015-10-19 |
2017-06-01 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
ES2928856T3
(es)
|
2015-11-19 |
2022-11-23 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
ES2916874T3
(es)
*
|
2015-12-17 |
2022-07-06 |
Incyte Corp |
Derivados de N-fenil-piridina-2-carboxamida y su uso como moduladores de la interacción proteína/proteína PD-1/PD-L1
|
AU2016379372A1
(en)
|
2015-12-22 |
2018-08-02 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
CA2997859C
(en)
|
2016-02-29 |
2024-06-04 |
F. Hoffmann-La Roche Ag |
Dosage form compositions comprising an inhibitor of bruton's tyrosine kinase
|
AR108396A1
(es)
|
2016-05-06 |
2018-08-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
EP3464279B1
(en)
|
2016-05-26 |
2021-11-24 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
CA3028685A1
(en)
|
2016-06-20 |
2017-12-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
CN109475536B
(zh)
|
2016-07-05 |
2022-05-27 |
百济神州有限公司 |
用于治疗癌症的PD-l拮抗剂和RAF抑制剂的组合
|
ES2930092T3
(es)
|
2016-07-14 |
2022-12-07 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
IL293319A
(en)
|
2016-08-16 |
2022-07-01 |
Beigene Ltd |
Crystal structure of s)-7-(1-acryloylpiperidin-4-yl)-2-(4-)phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo(1,5-a)pyrimidine-3-carboxamide , preparation methods and its uses
|
US11701357B2
(en)
|
2016-08-19 |
2023-07-18 |
Beigene Switzerland Gmbh |
Treatment of B cell cancers using a combination comprising Btk inhibitors
|
MA46045A
(fr)
*
|
2016-08-29 |
2021-04-28 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
WO2018049191A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridone derivatives as hpk1 modulators and uses thereof for the treatment of cancer
|
US20180072718A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
AR109596A1
(es)
|
2016-09-09 |
2018-12-26 |
Incyte Corp |
Compuestos pirazolopiridina y sus usos
|
TW201811799A
(zh)
|
2016-09-09 |
2018-04-01 |
美商英塞特公司 |
吡唑并嘧啶化合物及其用途
|
KR20190058550A
(ko)
|
2016-09-19 |
2019-05-29 |
메이 파마, 아이엔씨. |
병용 요법
|
PT3558990T
(pt)
|
2016-12-22 |
2022-11-21 |
Incyte Corp |
Derivados de tetrahidroimidazo[4,5-c]piridina como indutores da internalização de pd-l1
|
UA126394C2
(uk)
|
2016-12-22 |
2022-09-28 |
Інсайт Корпорейшн |
Похідні бензоксазолу як імуномодулятори
|
MA47120A
(fr)
|
2016-12-22 |
2021-04-28 |
Incyte Corp |
Dérivés pyridine utilisés en tant qu'immunomodulateurs
|
ES2874756T3
(es)
|
2016-12-22 |
2021-11-05 |
Incyte Corp |
Derivados de triazolo[1,5-A]piridina como inmunomoduladores
|
EP3573989A4
(en)
|
2017-01-25 |
2020-11-18 |
Beigene, Ltd. |
CRYSTALLINE FORMS OF (S) -7- (1- (BUT-2-YNOYL) -PIPERIDINE-4-YL) -2- (4-PHENOXYPHENYL) -4,5,6,7-TETRAHYDROPYRAZOLO [1,5-A ] PYRIMIDINE-3-CARBOXAMIDE, MANUFACTURING AND USES THEREOF
|
US20180228786A1
(en)
|
2017-02-15 |
2018-08-16 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
EP3602058A1
(en)
|
2017-03-24 |
2020-02-05 |
H. Hoffnabb-La Roche Ag |
Methods of treating autoimmune and inflammatory diseases
|
CN110799543A
(zh)
|
2017-06-26 |
2020-02-14 |
百济神州有限公司 |
肝细胞癌的免疫治疗
|
WO2019034009A1
(en)
|
2017-08-12 |
2019-02-21 |
Beigene, Ltd. |
BTK INHIBITOR WITH ENHANCED DOUBLE SELECTIVITY
|
AU2018321264A1
(en)
|
2017-08-25 |
2020-02-27 |
Kronos Bio, Inc. |
Polymorphs of Syk inhibitors
|
WO2019051199A1
(en)
|
2017-09-08 |
2019-03-14 |
Incyte Corporation |
6-CYANO-INDAZOLE COMPOUNDS AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) MODULATORS
|
US11786529B2
(en)
|
2017-11-29 |
2023-10-17 |
Beigene Switzerland Gmbh |
Treatment of indolent or aggressive B-cell lymphomas using a combination comprising BTK inhibitors
|
US10745388B2
(en)
|
2018-02-20 |
2020-08-18 |
Incyte Corporation |
Indazole compounds and uses thereof
|
UA128286C2
(uk)
|
2018-02-20 |
2024-05-29 |
Інсайт Корпорейшн |
Похідні n-(феніл)-2-(феніл)піримідин-4-карбоксаміду та родинні сполуки як інгібітори hpk1 для лікування раку
|
US10752635B2
(en)
|
2018-02-20 |
2020-08-25 |
Incyte Corporation |
Indazole compounds and uses thereof
|
IL313101A
(en)
|
2018-03-30 |
2024-07-01 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
US11299473B2
(en)
|
2018-04-13 |
2022-04-12 |
Incyte Corporation |
Benzimidazole and indole compounds and uses thereof
|
SG11202011165TA
(en)
|
2018-05-11 |
2020-12-30 |
Incyte Corp |
Tetrahydro-imidazo[4,5-c]pyridine derivatives as pd-l1 immunomodulators
|
US10899755B2
(en)
|
2018-08-08 |
2021-01-26 |
Incyte Corporation |
Benzothiazole compounds and uses thereof
|
WO2020068729A1
(en)
|
2018-09-25 |
2020-04-02 |
Incyte Corporation |
Pyrazolo[4,3-d]pyrimidine compounds as alk2 abd/or fgfr modulators
|
CA3130848A1
(en)
|
2019-02-22 |
2020-08-27 |
Kronos Bio, Inc. |
Solid forms of condensed pyrazines as syk inhibitors
|
CR20220097A
(es)
|
2019-08-06 |
2022-06-01 |
Incyte Corp |
Formas sólidas de un inhibidor de hpk1
|
CA3150434A1
(en)
|
2019-08-09 |
2021-02-18 |
Incyte Corporation |
Salts of a pd-1/pd-l1 inhibitor
|
US11401279B2
(en)
|
2019-09-30 |
2022-08-02 |
Incyte Corporation |
Pyrido[3,2-d]pyrimidine compounds as immunomodulators
|
BR112022009031A2
(pt)
|
2019-11-11 |
2022-10-11 |
Incyte Corp |
Sais e formas cristalinas de um inibidor de pd-1/pd-l1
|
IL302590A
(en)
|
2020-11-06 |
2023-07-01 |
Incyte Corp |
Process for preparing PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
|
US11780836B2
(en)
|
2020-11-06 |
2023-10-10 |
Incyte Corporation |
Process of preparing a PD-1/PD-L1 inhibitor
|
US11760756B2
(en)
|
2020-11-06 |
2023-09-19 |
Incyte Corporation |
Crystalline form of a PD-1/PD-L1 inhibitor
|
US11786531B1
(en)
|
2022-06-08 |
2023-10-17 |
Beigene Switzerland Gmbh |
Methods of treating B-cell proliferative disorder
|